BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 1606472)

  • 1. Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease.
    Mann VM; Cooper JM; Krige D; Daniel SE; Schapira AH; Marsden CD
    Brain; 1992 Apr; 115 ( Pt 2)():333-42. PubMed ID: 1606472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal.
    Schapira AH
    Mov Disord; 1994 Mar; 9(2):125-38. PubMed ID: 8196673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson's Disease Research Group.
    Schapira AH; Mann VM; Cooper JM; Krige D; Jenner PJ; Marsden CD
    Ann Neurol; 1992; 32 Suppl():S116-24. PubMed ID: 1510369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease.
    Ebadi M; Govitrapong P; Sharma S; Muralikrishnan D; Shavali S; Pellett L; Schafer R; Albano C; Eken J
    Biol Signals Recept; 2001; 10(3-4):224-53. PubMed ID: 11351130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 31P magnetic resonance spectroscopy study of mitochondrial function in skeletal muscle of patients with Parkinson's disease.
    Taylor DJ; Krige D; Barnes PR; Kemp GJ; Carroll MT; Mann VM; Cooper JM; Marsden CD; Schapira AH
    J Neurol Sci; 1994 Aug; 125(1):77-81. PubMed ID: 7964892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage.
    Flønes IH; Fernandez-Vizarra E; Lykouri M; Brakedal B; Skeie GO; Miletic H; Lilleng PK; Alves G; Tysnes OB; Haugarvoll K; Dölle C; Zeviani M; Tzoulis C
    Acta Neuropathol; 2018 Mar; 135(3):409-425. PubMed ID: 29270838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease.
    Schapira AH; Mann VM; Cooper JM; Dexter D; Daniel SE; Jenner P; Clark JB; Marsden CD
    J Neurochem; 1990 Dec; 55(6):2142-5. PubMed ID: 2121905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group.
    Krige D; Carroll MT; Cooper JM; Marsden CD; Schapira AH
    Ann Neurol; 1992 Dec; 32(6):782-8. PubMed ID: 1471869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No evidence for altered muscle mitochondrial function in Parkinson's disease.
    Anderson JJ; Bravi D; Ferrari R; Davis TL; Baronti F; Chase TN; Dagani F
    J Neurol Neurosurg Psychiatry; 1993 May; 56(5):477-80. PubMed ID: 8505638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction in movement disorders.
    Schulz JB; Beal MF
    Curr Opin Neurol; 1994 Aug; 7(4):333-9. PubMed ID: 7952242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial respiratory chain function in multiple system atrophy.
    Gu M; Gash MT; Cooper JM; Wenning GK; Daniel SE; Quinn NP; Marsden CD; Schapira AH
    Mov Disord; 1997 May; 12(3):418-22. PubMed ID: 9159739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress as a cause of Parkinson's disease.
    Jenner P
    Acta Neurol Scand Suppl; 1991; 136():6-15. PubMed ID: 1801537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unaltered respiratory chain enzyme activity and mitochondrial DNA in skeletal muscle from patients with idiopathic Parkinson's syndrome.
    Reichmann H; Janetzky B; Bischof F; Seibel P; Schöls L; Kuhn W; Przuntek H
    Eur Neurol; 1994; 34(5):263-7. PubMed ID: 7995300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial complex I deficiency in Parkinson's disease.
    Schapira AH
    Adv Neurol; 1993; 60():288-91. PubMed ID: 8420145
    [No Abstract]   [Full Text] [Related]  

  • 16. Iron-dependent enzymes in Parkinson's disease.
    Reichmann H; Janetzky B; Riederer P
    J Neural Transm Suppl; 1995; 46():157-64. PubMed ID: 8821051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease.
    Jenner P
    Acta Neurol Scand Suppl; 1993; 146():6-13. PubMed ID: 8333254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Idiopathic Parkinson disease and mitochondrial functions].
    Tranchant C; Weess C; Warter JM
    Rev Neurol (Paris); 1995 Mar; 151(3):157-60. PubMed ID: 7676150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson's disease patients.
    DiDonato S; Zeviani M; Giovannini P; Savarese N; Rimoldi M; Mariotti C; Girotti F; Caraceni T
    Neurology; 1993 Nov; 43(11):2262-8. PubMed ID: 8232940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria in the etiology and pathogenesis of Parkinson's disease.
    Schapira AH; Gu M; Taanman JW; Tabrizi SJ; Seaton T; Cleeter M; Cooper JM
    Ann Neurol; 1998 Sep; 44(3 Suppl 1):S89-98. PubMed ID: 9749579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.